Literature DB >> 32342330

Efficacy of stereotactic radiosurgery for radiation-induced meningiomas.

Michael Huo1,2,3, Normand Laperriere4,5, Monique van Prooijen4,5, David Shultz4,5, Catherine Coolens4,5, Mojgan Hodaie5,6, Michael Cusimano5,7, Fred Gentili5,6, Gelareh Zadeh5,6, David Payne4,5, Michael Schwartz5,6, Derek S Tsang4,5.   

Abstract

PURPOSE: Stereotactic radiosurgery is an established treatment option for sporadic meningiomas, though limited data exists for radiation-induced lesions.
METHODS: Patients treated with cobalt-60 radiosurgery between October 2005 and December 2018 in an institutional registry were reviewed. Single fraction treatments were prescribed to the 50% isodose line. Lesions were deemed to be radiation-induced according to standard criteria previously established by Cahan et al.
RESULTS: A total of 37 patients with 72 lesions were analysed. Median follow up per patient was 44 months (range, 1.4-150.7 months). Median age at initial radiotherapy was 5 years (4 months-48 years), and at radiosurgery was 38 years. Of the 72 lesions, 62 were grade 1 (n = 4) or radiologically-diagnosed (n = 58), six were grade 2 and four were grade 3. Median lesion volume was 2.13 cc (0.04-13.8 cc), while the median radiosurgery margin dose was 13 Gy. Local control, on a per lesion basis, was 88.6% at 5 years (95% confidence interval [CI] 72.3-95.6). For grade 1 or radiologically-diagnosed lesions, local control was 96.6% at 5 years (95% CI 77.9-99.5), whereas those with grade 2 or higher lesions had a local control of 40% at 5 years (95% CI 5.2-75.3, p = 0.005). Radiologic oedema developed in 17 lesions (23.6%) and was symptomatic in 12 patients (16.7%). Doses above 12 Gy were not associated with local control probability (p = 0.292).
CONCLUSION: Radiosurgery is an effective treatment option for grade 1 or radiologically-diagnosed radiation-induced meningiomas, with 12 Gy appearing to be a sufficient dose.

Entities:  

Keywords:  Meningioma; Radiation-induced meningioma; Radiosurgery; Radiotherapy; Stereotactic

Mesh:

Substances:

Year:  2020        PMID: 32342330     DOI: 10.1007/s11060-020-03515-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  2 in total

1.  Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery.

Authors:  Niema B Razavian; Corbin A Helis; Adrian Laxton; Stephen Tatter; J Daniel Bourland; Ryan Mott; Glenn J Lesser; Roy Strowd; Jaclyn J White; Michael D Chan; Christina K Cramer
Journal:  J Neurooncol       Date:  2022-10-12       Impact factor: 4.506

2.  The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.

Authors:  Conor S Gillespie; Abdurrahman I Islim; Basel A Taweel; Christopher P Millward; Siddhant Kumar; Nitika Rathi; Shaveta Mehta; Brian J Haylock; Nicola Thorp; Catherine E Gilkes; David D A Lawson; Samantha J Mills; Emmanuel Chavredakis; Jibril Osman Farah; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2021-04-22       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.